Milestone Pharmaceuticals Inc. revenue for the last year amounted to 1.00 M USD, the most of which — 1.00 M USD — came from its highest performing source at the moment, Cardiovascular Medicines, the year earlier bringing 5.00 M USD. The greatest contribution to the revenue figure was made by Canada — last year it brought Milestone Pharmaceuticals Inc. 1.00 M USD, and the year before that — 5.00 M USD.